At the hearing, Dawn O’Connell, the assistant secretary for preparedness and response at the Department of Health and Human Services, said there were 737 million N95 masks in the government’s strategic national stockpile, and that additional contracts for such masks would most likely be finalized by February. The government is asking potential contractors to make 141 million of the masks each month at a “surge capacity,” she said.
Over and over, senators from both parties returned to the administration’s efforts to meet the demand for tests, and its sometimes conflicting recommendations on when to use them.
Senator Patty Murray, Democrat of Washington and the committee’s chairwoman, praised the administration’s work to supply vaccines and treatments to Americans, but she said that health workers were still spread far too thin and that schools were “worried they’ll have to shut down again if they can’t get the support for testing they need.”
Senator Richard M. Burr of North Carolina, the panel’s top Republican, criticized the administration’s promise to deliver 500 million rapid tests to the homes of Americans, saying that Mr. Biden had pledged to do so without having the tests in hand.
“Try to get the administration to refrain from making these proclamations until we’ve got the product,” Mr. Burr said to Ms. O’Connell.
Ms. O’Connell said that when federal health officials saw Omicron sweeping across South Africa and Europe, “we immediately reached out to our manufacturers to understand any supply constraints they had and to evaluate their surge capacity” for producing tests.
“We have also met daily with them to make sure that they have what they need from their suppliers,” she said, adding that the Defense Production Act had been used in recent weeks to help free up supplies and manufacturing capacity.